Chillarón JJ, Roux JAFL, Benaiges D, Pedro-Botet J. Subclinical cardiovascular disease in type 2 diabetes mellitus: To screen or not to screen. World J Clin Cases 2014; 2(9): 415-421 [PMID: 25232543 DOI: 10.12998/wjcc.v2.i9.415]
Corresponding Author of This Article
Dr. Juan J Chillarón, Department of Endocrinology and Nutrition, Hospital del Mar, Passeig Marítim, 25-29, 08003 Barcelona, Spain. jchillaron@parcdesalutmar.cat
Research Domain of This Article
Endocrinology & Metabolism
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Sep 16, 2014; 2(9): 415-421 Published online Sep 16, 2014. doi: 10.12998/wjcc.v2.i9.415
Subclinical cardiovascular disease in type 2 diabetes mellitus: To screen or not to screen
Juan J Chillarón, Juana A Flores-Le Roux, David Benaiges, Juan Pedro-Botet
Juan J Chillarón, Juana A Flores-Le Roux, David Benaiges, Juan Pedro-Botet, Department of Endocrinology and Nutrition, Hospital del Mar, Passeig Marítim 25-29, 08003 Barcelona, Spain
Juan J Chillarón, Juana A Flores-Le Roux, David Benaiges, Juan Pedro-Botet, Institut Municipal d´Investigacions Mèdiques, Passeig Marítim 25-29, 08003 Barcelona, Spain
Juan J Chillarón, Juana A Flores-Le Roux, David Benaiges, Juan Pedro-Botet, Departament de Medicina, Universitat Autònoma de Barcelona, 08193 Cerdanyola (NOT Sardañola) del Vallés, Barcelona, Spain
Author contributions: All the authors contributed to this paper.
Correspondence to: Dr. Juan J Chillarón, Department of Endocrinology and Nutrition, Hospital del Mar, Passeig Marítim, 25-29, 08003 Barcelona, Spain. jchillaron@parcdesalutmar.cat
Telephone: +34-93-2483902 Fax: +34-93-2483337
Received: March 26, 2014 Revised: April 30, 2014 Accepted: July 12, 2014 Published online: September 16, 2014 Processing time: 182 Days and 19.8 Hours
Core Tip
Core tip: The prevalence of type 2 diabetes mellitus (T2DM) has risen in recent decades, and cardiovascular disease remains the leading cause of death in this population. Several clinical trials have demonstrated the benefit of tight control of risk factors on the incidence and mortality of cardiovascular disease. The current diagnostic procedures for subclinical cardiovascular disease in T2DM patients have not been shown to improve prognosis or mortality, probably because they do not categorize cardiovascular risk. Improvements in the reliability of diagnostic tests, with fewer side effects and better cost efficiency, may better help to stratify cardiovascular risk in this group of patients, and further evaluation on this topic should be considered.
